Earth Science Tech (ETST) Cash from Investing Activities (2017 - 2026)
Earth Science Tech (ETST) posted Cash from Investing Activities of -$460641.0 for Q1 2026, up 8.41% on a QoQ basis from -$502948.0 in Q4 2025, and down 553.77% year-over-year from $101513.8 in Q1 2025.
Earth Science Tech (ETST) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Earth Science Tech's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$460641.0 for Q1 2026.
- Quarterly Cash from Investing Activities fell 553.77% year-over-year to -$460641.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 1.22% YoY) and the FY2026 annual result came in at -$1.9 million, down 1.22% from the prior year.
- Cash from Investing Activities was -$460641.0 for Q1 2026 at Earth Science Tech, up from -$502948.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$8870.0 in Q3 2024 and bottomed at -$1.7 million in Q4 2024.
- A 3-year average of -$473215.9 and a median of -$366606.5 in 2025 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 70.45% in 2025, while the deepest fall reached 2972.97% in 2025.
- Earth Science Tech's Cash from Investing Activities stood at -$1.7 million in 2024, then soared by 70.45% to -$502948.0 in 2025, then advanced by 8.41% to -$460641.0 in 2026.
- Business Quant data shows ETST's Cash from Investing Activities at -$460641.0 in Q1 2026, -$502948.0 in Q4 2025, and -$272572.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.49 Bn | 30.55 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 23.13 Bn | 20.97 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Earth Science Tech | 33.70 Mn | 31.55 Mn | 6.27 Mn | -460,641.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -460,641.00 |
| Mar 31, 2026 | -460,641.00 |
| Dec 31, 2025 | -502,948.00 |
| Dec 31, 2025 | -502,948.00 |
| Sep 30, 2025 | -272,572.00 |
| Sep 30, 2025 | -272,572.00 |
| Jun 30, 2025 | -668,216.00 |
| Jun 30, 2025 | -668,216.00 |
| Mar 31, 2025 | -70,459.00 |
| Mar 31, 2025 | -70,459.00 |
| Dec 31, 2024 | -1.70 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -8,870.00 |
| Sep 30, 2024 | -8,870.00 |
| Jun 30, 2024 | -99,725.00 |
| Jun 30, 2024 | -99,725.00 |
| Jun 30, 2021 | 1,712.00 |
| Jun 30, 2021 | 1,712.00 |
| Jun 30, 2017 | 1,101.00 |
| Jun 30, 2017 | 1,101.00 |